Position
Chief Technology Officer
Company
Akero Therapeutics
South San FranciscoBiotechnologyHealth CareTherapeuticsDescription
Akero Therapeutics, Inc. announced the appointment of Scott Gangloff as Chief Technology Officer. Scott brings a strong track record of success in biopharmaceutical development and manufacturing to Akero, with nearly 30 years of experience.
Quick answer
Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer (April 30, 2024). Akero Therapeutics is based in South San Francisco, California, United States.
- Who is the new Chief Technology Officer at Akero Therapeutics?
- Akero Therapeutics named Scott Gangloff Chief Technology Officer, announced April 30, 2024.
- What did Akero Therapeutics announce on April 30, 2024?
- Akero Therapeutics, Inc. announced the appointment of Scott Gangloff as Chief Technology Officer. Scott brings a strong track record of success in biopharmaceutical development and manufacturing to Akero, with nearly 30 years of experience.
- What does Akero Therapeutics do?
- Akero Therapeutics, Inc. is a clinical-stage company developing transformational treatments for patients with serious metabolic disease.
- Where is Akero Therapeutics based?
- Akero Therapeutics is based in South San Francisco, California, United States.
- Which similar companies made leadership changes around the same time?
- Insitro (April 30, 2024), BioVaxys Technology Corp. (April 30, 2024), Stoke Therapeutics, Inc. (April 29, 2024) and Evox Therapeutics Ltd (April 29, 2024) also announced leadership changes within 45 days of Akero Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- insitro Appoints Emily Fox, Ph.D. as Senior Vice President of AI/Machine Learning (April 30, 2024)
- BioVaxys Technology Corp Appoints Christopher Cherry as Chief Financial Officer (April 30, 2024)
- Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer (April 29, 2024)
- Evox Therapeutics Appoints Dr. Per Lundin as Chief Executive Officer (April 29, 2024)
- CureVac N.V. Appoints Thaminda Ramanayake as Chief Business Officer (April 29, 2024)
- Immunome Names Kinney Horn as Chief Business Officer (May 2, 2024)
Who to call at Akero Therapeutics, and when
A new leader at Akero Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Akero Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Akero Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Akero Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Akero Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Akero Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.